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Abstract
Background—Vaccination promotion strategies are recommended in Women, Infants, and 
Children (WIC) settings for eligible children at risk for under-immunization due to their low-
income status.
Purpose—To determine coverage levels of WIC and non-WIC participants and assess 
effectiveness of immunization intervention strategies.
Methods—The 2007–2011 National Immunization Surveys were used to analyze vaccination 
histories and WIC participation among children aged 24–35 months. Grantee data on 
immunization activities in WIC settings were collected from the 2010 WIC Linkage Annual 
Report Survey. Coverage by WIC eligibility and participation status and grantee-specific coverage 
by intervention strategy were determined at 24 months for select antigens. Data were collected 
2007–2011 and analyzed in 2013.
Results—Of 13,183 age-eligible children, 5,699 (61%, weighted) had participated in WIC, of 
which 3,404 (62%, weighted) were current participants. In 2011, differences in four or more doses 
of the diphtheria, tetanus toxoid, and acellular pertussis (DTaP) vaccine by WIC participation 
status were observed: 86% (ineligible); 84% (current); 77% (previous); and 69% (never-eligible). 
Children in WIC exposed to an immunization intervention strategy had higher coverage levels than 
WIC-eligible children who never participated, with differences as great as 15% (DTaP).
Conclusions—Children who never participated in WIC, but were eligible, had the lowest 
vaccination coverage. Current WIC participants had vaccination coverage comparable to more 
affluent children, and higher coverage than previous WIC participants.
Introduction
Since 1996, the Advisory Committee on Immunization Practices (ACIP) has recommended 
implementation of interventions in Special Supplemental Nutrition Program for Women, 
Infants, and Children (WIC) settings to promote vaccination of low-income preschool-aged 
eligible children at risk for under-vaccination.1–3 Interventions are based on assessment of a 
child’s immunization status and referral to a provider if under-immunized (i.e., Assessment 
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and Referral [A&R]) and may be supplemented by additional strategies.3 Supplemental 
strategies may include monthly voucher pick-up (MVP); outreach and tracking (O&T); and 
parental incentives (PI). Descriptions are well documented.4,5
Several studies6–16 demonstrated the effectiveness of WIC-based strategies. However, no 
studies assessed coverage across multiple years and few compared coverage between WIC 
and non-WIC participants.5,17,18 Therefore, the aims of this study were to determine (1) 




Data from the 2007–2011 National Immunization Surveys (NIS) were used to identify 
children representative of non-overlapping geographic areas, including the 50 U.S. states, 
eight U.S.-affiliated jurisdictions, six urban areas, and U.S. Virgin Islands (since 2009). 
Children are identified through a household telephone survey. Beginning in 2011, children 
may have been included from cell phone respondents. NIS sampling and analytical 
methodologies are previously described.19
The 2010 WIC-Linkage Annual Report Survey (WIC-LARS) was used to collect grantee-
specific information on WIC sites. Data include number of WIC sites conducting 
immunization linkage activities and strategy utilized. The survey is completed by grantee 
immunization programs annually. Prior approval of data collection activities was granted by 
CDC’s Research Ethics Review Board.
This analysis was limited to children aged 24–35 months residing in areas that provided 
WIC-LARS data, resulting in the inclusion of 54 geographic areas (hereafter, referred to as 
“grantees”). Children with missing provider type (n=126) or demographics (n=61) were 
excluded. In 2011, of the 13,508 children aged 24–35 months with provider data, 13,183 
children were eligible for inclusion. Characteristics of eligible children were similar from 
2007 to 2011; thus, data from 2011 are highlighted.
NIS data were used to assess the following provider-verified immunizations at age 24 
months: ≥4 doses containing diphtheria, tetanus toxoids, and acellular pertussis (DTaP), ≥1 
dose of measles, and the 4:3:1:3:3:1:4 vaccine series (≥4 doses of DTaP, ≥3 doses of polio, 
≥1 dose of measles, ≥3 doses of Haemophilus influenza type b (Hib), ≥3 doses of hepatitis B 
(HepB), ≥1 dose of varicella, and ≥4 doses of pneumococcal conjugate vaccine (PCV), 
modified with the exclusion of Hib (hereafter, referred to as “4:3:1:*:3:1:4”) due to the 
2007–2009 shortage.20,21
WIC status was based on parental responses to NIS questions as to whether a child ever and 
were currently receiving WIC benefits. Children never participating in WIC were further 
categorized based on their eligibility at time of interview, defined as having family income 
≤185% of the federal poverty level. The four resulting groups were (1) WIC ineligible; (2) 
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WIC eligible/never participated; (3) WIC eligible/previous participant; and (4) WIC eligible/
current participant.
Grantees implementing supplemental strategies among the majority of its total WIC sites 
were categorized by the strategy most widely implemented, as reported in the 2010WIC-
LARS. A grantee implementing the principal intervention only or with supplemental 
strategies was categorized as A&R Only or A&R Plus, respectively.
Data Analysis
Coverage by WIC status was examined. Estimates were adjusted for race (non-Hispanic 
white, non-Hispanic black, Hispanic, Asian, and other); mother’s age (≤19, 20–29, and ≥30 
years); mother’s education (less than versus high school graduate); region (city, suburb, and 
rural); health insurance; and immunization facility (private, public, military/hospital/other, 
and mixed).
Data were obtained from the 2011 NIS and 2010 WIC-LARS to determine grantee-specific 
estimates, by strategy, for current WIC participants and ineligibles at 24 months. 
Comparison between current and ineligible participants was conducted to test for differences 
in coverage.
Logistic models were used to determine coverage estimates and SEs. All models were 
estimated using SUDAAN, version 11 (RTI International, Research Triangle Park NC), to 
account for survey probability sampling and weighting. Data were collected during 2007–
2011 and analyzed in 2013.
Results
In 2011, 5,699 (61%, weighted) of 13,183 children had a history of WIC participation, of 
which 3,404 (62%, weighted) were enrolled at the time of interview. Among children who 
never participated, 687 (13%) were WIC-eligible. Race, mother’s age and education, region, 
health insurance, and immunization facility differed significantly by WIC status (data not 
shown).
Differences in immunization coverage were observed at age 24 months. WIC-eligible 
children who never participated had the lowest rates for nearly all vaccines from2007 to 
2011 (Table 1). Their series coverage ranged from 7% to 16% and 5% to 19% lower than 
WIC-ineligible and current participants, respectively. Similarly, significant gaps between 
previous and current WIC participants existed for nearly all vaccines from 2007 to 2011. 
Previous participants had series coverage ranging from 1% (2009) to 10% (2010) lower than 
current participants. No significant differences in coverage for any vaccine were observed 
between current participants and children ineligible for WIC, except for DTaP in 2010.
In comparing series coverage at 24 months between current participants and more affluent 
ineligibles, 23 (88%) of 26 grantees categorized as primarily implementing A&R Only 
strategies had no significant differences in coverage (Table 2). These 23 grantees had 
coverage among current participants ranging from 54% to 87% (median=72%), similar to 
that among ineligibles, ranging from 57% to 85% (median=72%). However, in three 
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grantees, coverage among current participants was 19%–24% lower compared to ineligibles. 
Similar results were seen among grantees categorized as primarily implementing A&R Plus 
strategies. Series coverage at 24 months among current participants (range=56%–88%, 
median=68%) was comparable to ineligibles (range=61%–89%, median=74%) (Table 2).
Discussion
These results support earlier findings on the benefits of WIC-based immunization 
interventions.5,17,18 Furthermore, the study reveals that eligible children who remain in WIC 
tend to have immunization coverage comparable to more affluent children. However, not all 
eligible children are benefiting from WIC. This study estimated that 8% of eligible children 
never made use of the program and among children who dis-enrolled, 72% still met income 
eligibility at time of interview.
The study findings should be considered within the context of limitations. First, WIC status 
was assessed at the time of interview and may be misclassified at age 24 months. Second, 
this study was unable to determine intervention by WIC site. Intervention was determined at 
the grantee level and may not represent what a child received. Studies determined 
MVP7,9,11,14 and increased assessments22 as effective strategies. Although measures were 
unavailable to determine which strategies led to increased coverage, grantee-specific rates 
suggest strategies are beneficial. Third, this study was unable to control for grantee-level 
factors potentially influencing coverage, including WIC resources, staffing, and variation in 
policies.18,23 Finally, this study is cross-sectional, thereby precluding a causal link, and data, 
although weighted to be representative, may remain biased.
Poverty remains a predictor for under-vaccination; however, low-income children 
participating in WIC were shown to have immunization rates comparable to more affluent 
children. Although the Vaccines for Children program has bridged gaps, coverage among 
poorer children remains lower.24 Thus, increased efforts to enroll and retain eligible children 
in WIC are needed to ensure they benefit from vaccination promotion strategies.
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Table 1
Coverage at 24 months, by WIC eligibility and status, 2007–2011 NIS, % SE (weighted)
Doses














  DTaP, ≥4 86 (1.0) 79 (2.7)c 76 (1.7)c 84 (1.1)d
  Measles, ≥1 94 (0.6) 89 (2.1)c 89 (1.3)c 94 (0.7)d,e
  4:3:1:*:3:1:4b 68 (1.4) 61 (3.7) 59 (1.8)c 66 (1.6)d
2008
  DTaP, ≥4 85 (1.1) 75 (3.0)c 78 (1.6)c 83 (1.2)d,e
  Measles, ≥1 93 (0.8) 88 (2.3)c 90 (1.3)c 94 (0.8)d,e
  4:3:1:*:3:1:4b 70 (1.3) 63 (3.2)c 63 (1.9)c 69 (1.5)d
2009
  DTaP, ≥4 83 (1.3) 69 (3.4)c 76 (1.7)c,e 83 (1.1)d,e
  Measles, ≥1 91 (1.1) 85 (2.3)c 90 (1.1)e 93 (0.8)e
  4:3:1:*:3:1:4b 69 (1.4) 53 (3.5)c 62 (1.9)c,e 72 (1.4)d,e
2010
  DTaP, ≥4 86 (1.0) 77 (3.6)c 77 (1.7)c 82 (1.3)c,d
  Measles, ≥1 91 (0.8) 91 (1.8) 90 (1.1) 93 (0.8)d
  4:3:1:*:3:1:4b 68 (1.3) 57 (4.1)c 63 (1.9)c 64 (1.5)
2011
  DTaP, ≥4 86 (1.1) 69 (3.0)c 77 (1.7)c,e 84 (1.1)d,e
  Measles, ≥1 92 (0.7) 83 (2.6)c 90 (1.2)e 94 (0.7)d,e
  4:3:1:*:3:1:4b 72 (1.4) 56 (3.1)c 64 (1.9)c,e 71 (1.4)d,e
Note: Logistic regression estimates adjusted for race, mother’s age and education, region, health insurance, and immunization facility; weighted to 
account for sampling. Boldface indicates statistical significance.
a
WIC income eligibility and participation status determined at time of interview; income eligibility based on family income ≤185% of federal 
poverty level.
b
4:3:1:*:3:1:4= ≥4 doses of DTaP, ≥3 doses of poliovirus, ≥1 dose of measles, ≥3 doses of Hib, ≥3 doses of HepB, ≥1 dose of varicella, and ≥4 
doses of PCV, excluding Hib.
c
Significant difference in coverage compared to children never receiving WIC benefits and not income eligible (p<0.05).
d
Significant difference in coverage compared to children previously receiving WIC benefits (p<0.05).
e
Significant difference in coverage compared to children never receiving WIC benefits and income eligible (p<0.05).
DTaP, diphtheria, tetanus toxoids, and acelluar pertussis–containing vaccine; HepB, hepatitis B; Hib, Haemophilus influenza type b; NIS, National 
Immunization Surveys; PCV, pneumococcal conjugate vaccine; WIC, Special Supplemental Nutrition Program for Women, Infants, and Children.
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